Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Evolva statement to SER communication
Evolva statement to SER communication
Evolva statement to SER communication
MaaT Pharma Presents Promising Detailed Results from Completed Phase 1b Trial with MaaT033 at the 64th ASH Annual Meeting: https://mms.businesswire.com/media/20211211005036/en/729326/5/Nov_2018_new_version_MaaT_Pharma_logo.jpg
MaaT Pharma Presents Promising Detailed Results from Completed Phase 1b Trial with MaaT033 at the 64th ASH Annual Meeting


Regulatory News:



MaaT Pharma (EURONEXT: MAAT – the “Company”), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving

Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trialhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial


Pfizer Inc. (NYSE:PFE) today announced 10.4 month follow-up data from the pivotal Phase 2 MagnetisMM-3 clinical trial suggesting elranatamab, a B-cell maturation antigen (BCMA)-CD3-targeted

MaaT Pharma Presents Compelling Consolidated MaaT013 Clinical Data at the 64th ASH Annual Meeting: https://mms.businesswire.com/media/20211211005036/en/729326/5/Nov_2018_new_version_MaaT_Pharma_logo.jpg
MaaT Pharma Presents Compelling Consolidated MaaT013 Clinical Data at the 64th ASH Annual Meeting


Regulatory News:



MaaT Pharma (EURONEXT: MAAT – the “Company”), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving

Granite Declares Quarterly Dividend: https://mms.businesswire.com/media/20191118005918/en/662198/5/Granite-Logo-Color.jpg
Granite Declares Quarterly Dividend


Granite Construction Incorporated (NYSE: GVA) today announced that its Board of Directors has declared a quarterly cash dividend of $0.13 per common share. The dividend is payable on January 13

State Street Global Advisors Announces Share Splits for Four SPDR® ETFs: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24771/405px-State_Street_Corporation_logo.svg.png
State Street Global Advisors Announces Share Splits for Four SPDR® ETFs


State Street Global Advisors, the asset management business of State Street Corporation (NYSE: STT), today announced share splits on four SPDR ETFs. The splits will decrease the funds’ share prices

Albany International Increases Dividend: https://mms.businesswire.com/media/20210513005937/en/878052/5/AILogoJPGFormat.jpg
Albany International Increases Dividend


The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.25 per share on the Company’s Class A Common Stock, an increase of 19% over the prior

Essex Property Trust Declares Quarterly Distributions: https://mms.businesswire.com/media/20191108005660/en/625771/5/Essex_Logo_Black_%28002%29.jpg
Essex Property Trust Declares Quarterly Distributions


Essex Property Trust, Inc. (NYSE:ESS) announced today that its Board of Directors has declared a regular quarterly cash dividend of $2.20 per common share, payable January 13, 2023 to shareholders

Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
CI Financial Named a Top Employer for 2023: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Financial Named a Top Employer for 2023


CI Financial Corp. (“CI”) (TSX: CIX; NYSE: CIXX) has been named one of Greater Toronto’s Top Employers for 2023, an award that recognizes firms with progressive human resources practices and

Pfizer Declares First-Quarter 2023 Dividendhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Declares First-Quarter 2023 Dividend


Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company’s common stock to $0.41 for the first-quarter 2023 dividend

Travis Perkins: Director/PDMR Shareholding
Travis Perkins: Director/PDMR Shareholding
Travis Perkins: Director/PDMR Shareholding
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
EQS-Adhoc: va-Q-tec AG: Prospectively near-term conclusion of a Business Combination Agreement with EQT Private Equity and approval of a cash capital increase without subscription rights of approx. 10%
EQS-Adhoc: va-Q-tec AG: Prospectively near-term conclusion of a Business Combination Agreement with EQT Private Equity and approval of a cash capital increase without subscription rights of approx. 10%
EQS-Adhoc: va-Q-tec AG: Prospectively near-term conclusion of a Business Combination Agreement with EQT Private Equity and approval of a cash capital increase without subscription rights of approx. 10%
RPM to Announce Fiscal 2023 Second Quarter Results on January 5, 2023: https://mms.businesswire.com/media/20200903005685/en/818366/5/Rust-Oleum-logo+%28002%29.jpg
RPM to Announce Fiscal 2023 Second Quarter Results on January 5, 2023


RPM International Inc. (NYSE: RPM) announced today that it will release its financial results for the fiscal 2023 second quarter before the stock market opens on Thursday, January 5, 2023. The

Fifth Third offers tips on how to keep your money, credit and identity safe during the holiday shopping season: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24455/Fifth_Third_Bank.svg_%281%29.png
Fifth Third offers tips on how to keep your money, credit and identity safe during the holiday shopping season


The rise of online and mobile banking and electronic financial transactions have made life easier for consumers. However, without proper security measures, they can put you at risk for fraud and

Victory Capital Reports November 2022 Assets Under Management: https://mms.businesswire.com/media/20200331005113/en/460034/5/VC_Logo_2c.jpg
Victory Capital Reports November 2022 Assets Under Management


Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or the “Company”) today reported assets under management (AUM) of $161.5 billion as of November 30, 2022. The Company also reported

Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: RPS Group plc
Form 8.3 - The Vanguard Group, Inc.: RPS Group plc
Form 8.3 - The Vanguard Group, Inc.: RPS Group plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Aptorum Group Announces Offering of $3 Million Convertible Note due 2023: https://mms.businesswire.com/media/20191115005085/en/694467/5/aptorum_hori_HQ.jpg
Aptorum Group Announces Offering of $3 Million Convertible Note due 2023


Regulatory News:



Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in

Form 8.3 - The Vanguard Group, Inc.: Biffa plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc